- Home
- PUMP vs PHAR Comparison
PUMP vs PHAR Comparison
Compare PUMP & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUMP
- PHAR
- Stock Information
- Founded
- PUMP 2007
- PHAR 1988
- Country
- PUMP United States
- PHAR Netherlands
- Employees
- PUMP N/A
- PHAR N/A
- Industry
- PUMP Oilfield Services/Equipment
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- PUMP Energy
- PHAR Health Care
- Exchange
- PUMP Nasdaq
- PHAR Nasdaq
- Market Cap
- PUMP 634.9M
- PHAR 707.9M
- IPO Year
- PUMP 2017
- PHAR N/A
- Fundamental
- Price
- PUMP $5.08
- PHAR $10.96
- Analyst Decision
- PUMP Buy
- PHAR Strong Buy
- Analyst Count
- PUMP 6
- PHAR 3
- Target Price
- PUMP $9.00
- PHAR $30.00
- AVG Volume (30 Days)
- PUMP 2.2M
- PHAR 5.6K
- Earning Date
- PUMP 07-30-2025
- PHAR 07-31-2025
- Dividend Yield
- PUMP N/A
- PHAR N/A
- EPS Growth
- PUMP N/A
- PHAR N/A
- EPS
- PUMP N/A
- PHAR N/A
- Revenue
- PUMP $1,366,989,000.00
- PHAR $339,836,000.00
- Revenue This Year
- PUMP N/A
- PHAR $12.88
- Revenue Next Year
- PUMP $9.57
- PHAR $8.54
- P/E Ratio
- PUMP N/A
- PHAR N/A
- Revenue Growth
- PUMP N/A
- PHAR 22.44
- 52 Week Low
- PUMP $4.61
- PHAR $6.73
- 52 Week High
- PUMP $11.17
- PHAR $12.61
- Technical
- Relative Strength Index (RSI)
- PUMP 33.65
- PHAR 58.06
- Support Level
- PUMP $4.99
- PHAR $9.54
- Resistance Level
- PUMP $6.36
- PHAR $10.46
- Average True Range (ATR)
- PUMP 0.31
- PHAR 0.37
- MACD
- PUMP -0.09
- PHAR 0.10
- Stochastic Oscillator
- PUMP 12.37
- PHAR 81.20
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.